Rhys Izuagbe

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Respiratory Syndrome Coronavirus

Anti Inflammatory

Hyaluronic Acid

Particulate Matter

Top Venues

Communications biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, Ahmet Can Berkyurek, Roni Rasnic, Rhys Izuagbe, Myra Hosmillo, Shaul Ilan, Iris Grossman, Lauren McCormick, Christopher Cole Honeycutt, Timothy S Johnston, Matthew Gagne, Daniel C Douek, Ian G Goodfellow, Gregory James Hannon, Yaniv Erlich
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. Communications biology 6 (1) (2023)
Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, Ahmet Can Berkyurek, Roni Rasnic, Rhys Izuagbe, Myra Hosmillo, Shaul Ilan, Iris Grossman, Lauren McCormick, Christopher Cole Honeycutt, Timothy S Johnston, Matthew Gagne, Daniel C Douek, Ian G Goodfellow, Gregory James Hannon, Yaniv Erlich
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. Communications biology 6 (1) (2023)
Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, Ahmet Can Berkyurek, Roni Rasnic, Rhys Izuagbe, Myra Hosmillo, Shaul Ilan, Iris Grossman, Lauren McCormick, Christopher Cole Honeycutt, Timothy S Johnston, Matthew Gagne, Daniel C Douek, Ian G Goodfellow, Gregory James Hannon, Yaniv Erlich
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. Communications biology 6 (1) (2023)
Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, Ahmet Can Berkyurek, Roni Rasnic, Rhys Izuagbe, Myra Hosmillo, Shaul Ilan, Iris Grossman, Lauren McCormick, Christopher Cole Honeycutt, Timothy S Johnston, Matthew Gagne, Daniel C Douek, Ian G Goodfellow, Gregory James Hannon, Yaniv Erlich
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. Communications biology 6 (1) (2023)
Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, Ahmet Can Berkyurek, Roni Rasnic, Rhys Izuagbe, Myra Hosmillo, Shaul Ilan, Iris Grossman, Lauren McCormick, Christopher Cole Honeycutt, Timothy S Johnston, Matthew Gagne, Daniel C Douek, Ian G Goodfellow, Gregory James Hannon, Yaniv Erlich
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. Communications biology 6 (1) (2023)
Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, Ahmet Can Berkyurek, Roni Rasnic, Rhys Izuagbe, Myra Hosmillo, Shaul Ilan, Iris Grossman, Lauren McCormick, Christopher Cole Honeycutt, Timothy S Johnston, Matthew Gagne, Daniel C Douek, Ian G Goodfellow, Gregory James Hannon, Yaniv Erlich
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. Communications biology 6 (1) (2023)
Dinesh Aggarwal, Ben Warne, Aminu S Jahun, William L Hamilton, Thomas Fieldman, Louis du Plessis, Verity Hill, Beth Blane, Emmeline Watkins, Elizabeth Wright, Grant Hall, Catherine Ludden, Richard Myers, Myra Hosmillo, Yasmin Chaudhry, Malte L Pinckert, Iliana Georgana, Rhys Izuagbe, Danielle Leek, Olisaeloka Nsonwu, Gareth J Hughes, Simon Packer, Andrew J Page, Marina Metaxaki, Stewart Fuller, Gillian Weale, Jon Holgate, Christopher A Brown, null null, null null, null null, Rob Howes, Duncan McFarlane, Gordon Dougan, Oliver George Pybus, Daniela De Angelis, Patrick H Maxwell, Sharon J Peacock, Michael P Weekes, Chris Illingworth, Ewan M Harrison, Nicholas J Matheson, Ian G Goodfellow
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission. Nature communications 13 (1) (2022)